נאופרו 6 מ"ג / 24 שעות

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

ROTIGOTINE 6 MG / 24 HOUR

Verfügbar ab:

CTS LTD

ATC-Code:

N04BC09

Darreichungsform:

PATCHES

Verabreichungsweg:

TRANSDERMAL

Hergestellt von:

UCB MANUFACTURING IRELAND LTD

Therapiegruppe:

ROTIGOTINE

Anwendungsgebiete:

Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

Berechtigungsdatum:

2012-09-01